Rakovina Therapeutics Inc (RKV)

TSXV
Currency in CAD
0.13
+0.01(+8.33%)
Closed
RKV Scorecard
Full Analysis
Stock has taken a big hit over the last week
Fair Value
Day's Range
0.120.13
52 wk Range
0.050.23
Key Statistics
Edit
Bid/Ask
0.12 / 0.13
Prev. Close
0.12
Open
0.13
Day's Range
0.12-0.13
52 wk Range
0.05-0.23
Volume
57.03K
Average Volume (3m)
287.08K
1-Year Change
73.33%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RKV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Rakovina Therapeutics Inc Company Profile

Rakovina Therapeutics Inc., a biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets. Its preclinical product pipeline include kt-2000AI, an poly(ADP)-ribose polymerase (PARP) brain penetrant cancer therapy; kt-3000, a bi-functional small-molecule drug candidate; kt-3283 series for the treatment of PARP resistant adult and childhood cancers; and kt-4000, a DNA-damaging DDR inhibitors. It has a research collaboration with Variational AI Inc. to identify and develop novel small-molecule therapies against DNA-damage response (DDR) targets for the treatment of cancer. Rakovina Therapeutics Inc. was formerly known as Vincero Capital Corp. The company is headquartered in Vancouver, Canada. Rakovina Therapeutics Inc. operates as a subsidiary of NewGen Therapeutics, Inc.

Compare RKV to Peers and Sector

Metrics to compare
RKV
Peers
Sector
Relationship
P/E Ratio
−5.1x−3.8x−0.5x
PEG Ratio
0.41−0.010.00
Price/Book
5.5x0.3x2.6x
Price / LTM Sales
-2.0x3.0x
Upside (Analyst Target)
-136.8%56.3%
Fair Value Upside
Unlock−3.6%10.0%Unlock

Earnings

Latest Release
Apr 28, 2023
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

3.530
BBAI
+7.95%
18.40
WRD
+13.09%
1.120
BNZI
+29.78%
124.46
VST
+5.47%
33.14
HIMS
+5.07%

FAQ

What Is the Rakovina Therapeutics (RKV) Stock Price Today?

The Rakovina Therapeutics stock price today is 0.13

What Stock Exchange Does Rakovina Therapeutics Trade On?

Rakovina Therapeutics is listed and trades on the TSXV stock exchange.

What Is the Stock Symbol for Rakovina Therapeutics?

The stock symbol for Rakovina Therapeutics is "RKV."

What Is the Rakovina Therapeutics Market Cap?

As of today, Rakovina Therapeutics market cap is 17.54M.

What is Rakovina Therapeutics Earnings Per Share?

The Rakovina Therapeutics EPS is -0.044.

From a Technical Analysis Perspective, Is RKV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.